Elexacaftor Enrolling by Invitation Phase 3 Trials for Cystic Fibrosis (CF) Treatment

IndicationsStatusPurposePhase
Enrolling by InvitationTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04362761A Study Evaluating the Long-Term Safety of Elexacaftor Combination Therapy
NCT04058366Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy
NCT04183790Evaluation of Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are 6 Years of Age and Older